Literature DB >> 8613464

Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.

S Mazurek1, F Hugo, K Failing, E Eigenbrodt.   

Abstract

Isoelectric focusing of MCF-7 cell extracts revealed an association of the glycolytic enzymes glyceraldehyde 3-phosphate-dehydrogenase, phosphoglycerate kinase, enolase, and pyruvate kinase. This complex between the glycolytic enzymes is sensitive to RNase. p36 could not be detected within this association of glycolytic enzymes; however an association of p36 with a specific form of malate dehydrogenase was found. In MCF-7 cells three forms of malate dehydrogenase can be detected by isoelectric focusing: the mitochondrial form with an isoelectric point between 8.9 and 9.5, the cytosolic form with pl 5.0, and a p36-associated form with pl 7.8. The mitochondrial form comprises the mature mitochondrial isoenzyme (pl 9.5) and its precursor form (pl 8.9). Refocusing of the pl 7.8 form of malate dehydrogenase also gave rise to the mitochondrial isoenzyme. Thus, the pl 7.8 form of malate dehydrogenase is actually the mitochondrial isoenzyme retained in the cytosol by the association with p36. Addition of fructose 1,6-bisphosphate to the initial focusing column induced a quantitative shift of the pl 7.8 form of malate dehydrogenase to the mitochondrial forms (pl 8.9 and 9.5). In MCF-7 cells p36 is not phosphorylated in tyrosine. Kinetic measurements revealed that the pl 7.8 form of malate dehydrogenase has the lowest affinity for NADH. Compared to both mitochondrial forms the cytosolic isoenzyme has a high capacity when measured in the NAD --> NADH direction (malate --> oxaloacetate direction). The association of p36 with the mitochondrial isoenzyme may favor the flow of hydrogen from the cytosol into the mitochondria. Inhibition of cell proliferation by AMP which leads to an inhibition of glycolysis has no effect on complex formation by glycolytic and glutaminolytic enzymes in MCF-7 cells. AMP treatment leads to an activation of malate dehydrogenase, which correlates with the increase of pyruvate and the decrease of lactate levels, but has no effect on the distribution of the various malate dehydrogenase forms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613464     DOI: 10.1002/(SICI)1097-4652(199605)167:2<238::AID-JCP7>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  11 in total

Review 1.  Pyruvate kinase: Function, regulation and role in cancer.

Authors:  William J Israelsen; Matthew G Vander Heiden
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

2.  Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence.

Authors:  Werner Zwerschke; Sybille Mazurek; Petra Stöckl; Eveline Hütter; Erich Eigenbrodt; Pidder Jansen-Dürr
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

3.  Linking post-translational modifications and variation of phenotypic traits.

Authors:  Warren Albertin; Philippe Marullo; Marina Bely; Michel Aigle; Aurélie Bourgais; Olivier Langella; Thierry Balliau; Didier Chevret; Benoît Valot; Telma da Silva; Christine Dillmann; Dominique de Vienne; Delphine Sicard
Journal:  Mol Cell Proteomics       Date:  2012-12-27       Impact factor: 5.911

Review 4.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

5.  Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.

Authors:  S Mazurek; W Zwerschke; P Jansen-Dürr; E Eigenbrodt
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

6.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Identification of arsenic-binding proteins in human breast cancer cells.

Authors:  Xinyan Zhang; Fan Yang; Joong-Youn Shim; Kenneth L Kirk; D Eric Anderson; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2007-05-17       Impact factor: 8.679

Review 8.  Enzymatic complexes across scales.

Authors:  Panagiotis L Kastritis; Anne-Claude Gavin
Journal:  Essays Biochem       Date:  2018-10-26       Impact factor: 8.000

9.  The Cardiomyocyte RNA-Binding Proteome: Links to Intermediary Metabolism and Heart Disease.

Authors:  Yalin Liao; Alfredo Castello; Bernd Fischer; Stefan Leicht; Sophia Föehr; Christian K Frese; Chikako Ragan; Sebastian Kurscheid; Eloisa Pagler; Hao Yang; Jeroen Krijgsveld; Matthias W Hentze; Thomas Preiss
Journal:  Cell Rep       Date:  2016-07-21       Impact factor: 9.423

Review 10.  Metabolic Enzymes Enjoying New Partnerships as RNA-Binding Proteins.

Authors:  Alfredo Castello; Matthias W Hentze; Thomas Preiss
Journal:  Trends Endocrinol Metab       Date:  2015-10-28       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.